The data and trends illustrating the impact of opioids on the United States are staggering. From July 2016 through September 2017, the Centers for Disease Control and Prevention (CDC) reported a 30% increase in overdoses among men and a 24% increase among women.
In December 2018, the Opioid Healthcare Provider/Advocacy Working Group convened for a two-day advisory board meeting with representatives from the primary care, pain management, oral surgery, orthopedic surgery, addiction, and physician assistant healthcare provider community, and the DEA Educational Foundation, to address the opioid epidemic and create actionable steps to promote appropriate and responsible prescribing for individuals with acute and chronic pain to curb the impact of the growing crisis facing our communities.
At the end of this CME/CE activity, participants should be able to:
Supported by an educational grant from Johnson & Johnson.
List the types of medical professionals who will benefit from this course.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Dr. Abubaker has no disclosures to report.
Mr. Alden has no disclosures to report.
Ms. Judd reports that she is on the speakers bureau for Alkermes; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Sunovion Pharmaceuticals Inc. She is on the advisory board for ACADIA Pharmaceuticals Inc.; Neurocrine Biosciences, Inc.
Dr. Mir reports that he is a consultant for OrthoGrid Systems, Inc.; Smith & Nephew; StabilizOrtho; Trice Medical; Zimmer Biomet.
Dr. Schmidt has no disclosures to report.
Dr. Stanos reports that he receives research support from Grunenthal and is a consultant for SCILEX Pharmaceuticals, Inc.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-136-H08-P